Age(years) | 50 ± 16 |
---|---|
Male sex | 26(54.17%) |
Etiology | |
gallstone | 19(39.6%) |
hypertriglyceride | 15(31.2%) |
alcohol | 4(8.3%) |
idiopathic | 10(20.9%) |
Category | |
MAP | 21(43.8%) |
MSAP | 19(39.6%) |
SAP | 8(16.6%) |
Amylase(IU) at admission | 720(349.5–1581.25) |
CRP(mg/L) at admission | 73.59 ± 80.44 |
Comorbidities | 17(35.42%) |
APACHEIIscores at enrollment | 5.19 ± 3.66 |
SOFA scores at enrollment | 2(1–3) |
Balthazar scores at enrollment | 2(2–3.75) |
Lymphocyte (%) | 16.24 ± 9.60 |
Lymphocyte subsets | |
B cell (%) | 7.84 ± 5.89 |
T cell (%) | 68.92 ± 9.69 |
Helper T cell (%) | 42.65 ± 11.31 |
Cytotoxic T cell (%) | 23.38 ± 7.46 |
NK cell (%) | 15.49 ± 7.88 |
Tregs (%) | 5.55 ± 1.69 |
Activated effector T cell (%) | 5.62 ± 2.42 |
CD4+/CD8+ | 2.13 ± 1.18 |
CD127low/high | 1.15 ± 0.58 |